![]()
|
|
||||||||
(Received for publication, August 6, 1996, and in revised form, October 4, 1996)
From the Unitat de Bioquímica, Departament de
Ciències Fisiològiques Humanes i de la Nutriciò,
Universitat de Barcelona, Avinguda Diagonal 643, Barcelona 08028, Catalunya, Spain and the The activation of glycolytic flux is a
biochemical characteristic of growing cells. Several reports have
demonstrated the role of fructose 2,6-bisphosphate in this
process. In this paper we show that the levels of
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF2K/Fru-2,6-P2ase) mRNA are modulated in
response to serum and growth factors and this effect is due to
regulation of its transcription rate. The modulation of the expression
of this enzyme by growth factors differs according their mitogenic
effect; both lysophosphatidic acid and epidermal growth factor, when
added alone, increased the mRNA levels, but endothelin had no
effect. Furthermore, cAMP, which acts as an antimitogenic signal in
Rat-1 fibroblasts, produced a decrease in
6PF2K/Fru-2,6-P2ase mRNA and inhibited the effects of
lysophosphatidic acid and epidermal growth factor on
6PF2K/Fru-2,6-P2ase expression. PD 098059, a specific inhibitor of the activation of the mitogen-activated protein kinase, was able to prevent the effect of EGF on
6PF2K/Fru-2,6-P2ase gene expression. These results imply
that activation of mitogen-activated protein kinase is required for the
stimulation of the transcription of 6PF2K/Fru-2,6-P2ase by
EGF.
Volume 272, Number 5,
Issue of January 31, 1997
pp. 2846-2851
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
,
Department of
Biochemistry, University of Minnesota, Minneapolis, Minnesota
55455-0347
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
I. Meton, M. Egea, I. G. Anemaet, F. Fernandez, and I. V. Baanante Sterol Regulatory Element Binding Protein-1a Transactivates 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase Gene Promoter Endocrinology, July 1, 2006; 147(7): 3446 - 3456. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bando, T. Atsumi, T. Nishio, H. Niwa, S. Mishima, C. Shimizu, N. Yoshioka, R. Bucala, and T. Koike Phosphorylation of the 6-Phosphofructo-2-Kinase/Fructose 2,6-Bisphosphatase/PFKFB3 Family of Glycolytic Regulators in Human Cancer Clin. Cancer Res., August 15, 2005; 11(16): 5784 - 5792. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. X. Perez, T. Roig, A. Manzano, M. Dalmau, J. Boada, F. Ventura, J. L. Rosa, J. Bermudez, and R. Bartrons Overexpression of fructose 2,6-bisphosphatase decreases glycolysis and delays cell cycle progression Am J Physiol Cell Physiol, November 1, 2000; 279(5): C1359 - C1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Roy and D. M. Terada Activities of Glucose Metabolic Enzymes in Human Preantral Follicles: In Vitro Modulation by Follicle-Stimulating Hormone, Luteinizing Hormone, Epidermal Growth Factor, Insulin-Like Growth Factor I, and Transforming Growth Factor ß1 Biol Reprod, March 1, 1999; 60(3): 763 - 768. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |